Gentian Diagnostics ASA GENT
OSL · Norway · Health Technology
NOK 39.00+2.10 (+5.69%)
Market closed· · NOK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · NOK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | 2023-05-05 | — | — | — | NOK 31.40M | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.